DEERFIELD, IL, January 5, 2016 – Sterigenics International, the leading global provider of contract sterilization, gamma technologies and medical isotopes, today announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%. Expansion will be complete by Q2 2017. “We have committed more than $80 million in capital investments in the past year to support our customers’ growth strategies,” said Michael Mulhern, CEO of Sterigenics International. “In addition to our Fort Worth expansion, we tripled sterilization capacity at the Sterigenics West Memphis, Arkansas location; significantly expanded our Gurnee, Illinois irradiation facility and increased our global service capabilities with the acquisition of leading Latin American sterilization firm Companhia Brasileira de Esterilização (CBE).” “The Fort Worth expansion is the direct result of increased regional demand for Sterigenics irradiation services,” said Philip Macnabb, President of Sterigenics International LLC. “We are adding gamma processing capacity of up to 5 million cubic feet per year in Texas, with a product overlap system which will provide the capability to process numerous dose ranges and a wide variety of densities.” Opened in 1984, Sterigenics Fort Worth provides routine gamma, GammaStat® rapid processing, process validation and SteriPro® laboratory testing.
About Sterigenics International LLC
Sterigenics International LLC, along with its affiliates, is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 47 facilities in 12 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Through its SteriPro® Labs service, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Affiliate Nordion positions Sterigenics as the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR.